Detalhe da pesquisa
1.
Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells.
Immunity
; 51(3): 573-589.e8, 2019 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31474513
2.
Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome.
Eur J Immunol
; 50(1): 119-129, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31424086
3.
Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk.
Rheumatology (Oxford)
; 60(2): 785-801, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32810267
4.
Increased intra-articular granzyme M may trigger local IFN-λ1/IL-29 response in rheumatoid arthritis.
Clin Exp Rheumatol
; 38(2): 220-226, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31172927
5.
Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren's syndrome.
Rheumatology (Oxford)
; 58(10): 1740-1745, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31220315
6.
Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome.
Ann Rheum Dis
; 77(12): 1810-1814, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30185417
7.
Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis.
J Autoimmun
; 89: 162-170, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29371048
8.
microRNA downregulation in plasmacytoid dendritic cells in interferon-positive systemic lupus erythematosus and antiphospholipid syndrome.
Rheumatology (Oxford)
; 57(9): 1669-1674, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29873766
9.
Neutrophil extracellular trap release is associated with antinuclear antibodies in systemic lupus erythematosus and anti-phospholipid syndrome.
Rheumatology (Oxford)
; 57(7): 1228-1234, 2018 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29608758
10.
Systemic and local granzyme B levels are associated with disease activity, kidney damage and interferon signature in systemic lupus erythematosus.
Rheumatology (Oxford)
; 56(12): 2129-2134, 2017 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28968826
11.
Neutrophil extracellular traps and low-density granulocytes are associated with the interferon signature in systemic lupus erythematosus, but not in antiphospholipid syndrome.
Ann Rheum Dis
; 79(10): e135, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31177097
12.
Galectin-9 reflects the interferon signature and correlates with disease activity in systemic autoimmune diseases. Response to: 'Biomarkers: to be or not to be' by Yavuz and Rönnblom.
Ann Rheum Dis
; 79(1): e9, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30530825
13.
Targeting thromboinflammation in antiphospholipid syndrome.
J Thromb Haemost
; 21(4): 744-757, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36696191
14.
A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndrome.
medRxiv
; 2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38405993
15.
B-Cells and BAFF in Primary Antiphospholipid Syndrome, Targets for Therapy?
J Clin Med
; 12(1)2022 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36614819
16.
Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin use.
Ann Rheum Dis
; 75(12): e81, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27689737
17.
Signaling by the inhibitory receptor CD200R is rewired by type I interferon.
Sci Signal
; 14(704): eabb4324, 2021 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637328
18.
Targeted therapies in systemic sclerosis, myositis, antiphospholipid syndrome, and Sjögren's syndrome.
Best Pract Res Clin Rheumatol
; 34(1): 101485, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32067925
19.
Delineating the deranged immune system in the antiphospholipid syndrome.
Autoimmun Rev
; 15(1): 50-60, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26318678
20.
Increased B-cell activating factor (BAFF)/B-lymphocyte stimulator (BLyS) in primary antiphospholipid syndrome is associated with higher adjusted global antiphospholipid syndrome scores.
RMD Open
; 4(2): e000693, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30018806